Nanding, Zuilybeth S.

HRN: 18-60-81  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2022
CEFUROXIME 750MG (VIAL)
07/17/2022
07/24/2022
IV
500mg
Q8h
PCAP C UTI
Waiting Final Action 
07/19/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/19/2022
07/28/2022
PO
6ml
TID
Infectious Diarrhea
Waiting Final Action 
09/28/2022
CEFUROXIME 750MG (VIAL)
09/28/2022
10/05/2022
IV
390 Mg
Q8
AGE
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: